Developer of novel drugs designed to identifying novel molecular and cellular mechanisms that regulate tumor development and metastasis. The company's novel drugs offers cancer treatment, mainly leukemia and myeloma, enabling healthcare industries to develop novel therapeutics against these devastating diseases.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Corporate | 03-Oct-2018 | Completed | Generating Revenue | |||
5. Merger/Acquisition | 00000 | Completed | Generating Revenue | |||
4. Grant | 18-Mar-2009 | 00.00 | 00000 | Completed | Generating Revenue | |
3. Later Stage VC | 10-Jan-2007 | 00000 | 00000 | Completed | Generating Revenue | |
2. Grant | $600K | Completed | Startup | |||
1. Accelerator/Incubator | 01-Jul-2000 | Completed | Startup |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-3090315-A1 | Small molecules for treating cancer, inhibiting chemokine activity and/or inducing cell death | Pending | 15-May-2019 | 000000000 | |
EP-3759074-A4 | Small molecules for treating cancer, inhibiting chemokine activity and/or inducing cell death | Pending | 15-May-2019 | 0000000000 | |
EP-3759074-A1 | Small molecules for treating cancer, inhibiting chemokine activity and/or inducing cell death | Pending | 15-May-2019 | 000000000 | |
US-20200369617-A1 | Small molecules for treating cancer, inhibiting chemokine activity and/or inducing cell death | Pending | 15-May-2019 | 000000000 | |
ES-2818531-T3 | Small molecules to inhibit chemokine activity and / or cancer cell growth | Active | 17-Dec-2015 | C07D215/24 |
Name | Representing | Role | Since |
---|---|---|---|
Amnon Peled Ph.D | Biokine Therapeutics | Co-Founder, Chief Executive Officer, Chief Scientific Officer & Board Member | 000 0000 |
Anthony Stanton | Self | Board Member | 000 0000 |
Assaf Segal | Self | Board Member | 000 0000 |
H. Laurence Shaw MD | Self | Chairman | 000 0000 |
Ofer Goldberg | Clal Biotechnology Industries | Board Member | 000 0000 |